Company Filing History:
1 out of 141 
1 out of 1,744 
1 out of 17 
Years Active: 2023
Title: Maxim Durand: Innovator in Lung Allograft Research
Introduction
Maxim Durand is a notable inventor based in Blacy, France. He has made significant contributions to the field of medical research, particularly in the area of lung allograft survival. His innovative work has the potential to improve patient outcomes in transplant medicine.
Latest Patents
Maxim Durand holds a patent titled "CD24CD38 transitional B cells and CD9 as new biomarker of long-term human lung allograft survival." This invention relates to an in vitro method for determining the risk of chronic lung graft dysfunction in a human subject. The method involves measuring the level of CD9B cells in a blood sample, comparing it with reference values, and determining the risk of chronic lung graft dysfunction based on this comparison. He has 1 patent to his name.
Career Highlights
Throughout his career, Maxim Durand has worked with esteemed institutions such as Université de Nantes and Institut National de la Santé et de la Recherche Médicale. His research has focused on identifying biomarkers that can predict the success of lung transplants, which is crucial for enhancing patient care.
Collaborations
Maxim has collaborated with notable colleagues in his field, including Carole Brosseau and Antoine Magnan. Their combined expertise has contributed to advancements in understanding lung allograft survival.
Conclusion
Maxim Durand's innovative research and patent in the field of lung allograft survival highlight his commitment to improving medical outcomes for transplant patients. His work continues to pave the way for future advancements in this critical area of healthcare.